Thus, constitutive activation of β-catenin and NFκB signalling [286] or dual Apc/Kras mutations [287] can drive tumour formation both from crypt ISCs and villus epithelial cells in the small intestine [286] and colon [287], respectively. This evidence concerns the gene KRAS and neoplasm.